HOspitalized Patients and Clinical flUid Status, Assessment Using Point Of Care UltraSound

ConditionVolume Status
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFlevoziekenhuis

About this trial

Point of care ultrasound (POCUS) of the inferior vena cava (IVC) is a tool for assessing volume status through ultrasonography. Using a point of care ultrasound device, the physician can perform an ultrasound of the vena cava at the bedside. Previous research has demonstrated a correlation between right atrial pressure and the vena cava's diameter. Nonetheless, the majority of research has been conducted in critically ill populations to predict fluid responsiveness in patients with more complex hemodynamics. There is limited data available on the value of IVC ultrasound in the sub-acute setting on the regular ward for clinical decision-making regarding whether a patient is hypovolemic or hypervolemic. This study's objective is to assess the diagnostic utility of point-of-care ultrasonography of the IVC, by using a standardized methodology, performed by qualified ward physicians in a conventional nursing ward.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient is over 18 years old.

Patient has a clinical indication for making a IVC ultrasound.

Patient is admitted until at least 24 hours after the first ultrasound.

Disqualifiers

Patients who are using vasopressors at the time of the ultrasound.

Patients who require invasive or non-invasive (optiflow, CPAP, BPAP) ventilation.

Trial population

Adult patients admitted to the general ward with a clinical indication for performing VCI ultrasound.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • POCUS performed on clinical indication

    Diagnostic test

    POCUS performed on clinical indication

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Volume status

Depleted, overloaded, or normal volume status at baseline, determined 48 hours after performing the ultrasound.

Time frame
48 hours

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.